Recent News

• 03.19.2026 - Greenwich LifeSciences Announces Addition of City of Hope to FLAMINGO-01
• 03.18.2026 - Greenwich LifeSciences Provides Update on Upcoming AACR Meeting
• 03.17.2026 - Greenwich LifeSciences Provides Update Showing Continued Reduction in Recurrence Rate in the Open Label Arm of FLAMINGO-01
• 03.16.2026 - Greenwich LifeSciences Announces Use of Commercially Manufactured GP2 in FLAMINGO-01
• 03.03.2026 - Greenwich LifeSciences Provides Update on Increased Patient Screen Rate in FLAMINGO-01
• 02.24.2026 - Greenwich LifeSciences Announces Acceptance of Two Abstracts at AACR Annual Meeting 2026
• 01.27.2026 - Greenwich LifeSciences Provides Update on FLAMINGO-01 Cash Burn Rate and Financing Strategy
• 01.22.2026 - Greenwich LifeSciences Announces FDA Approves Use of Commercially Manufactured GP2 in FLAMINGO-01
• 12.29.2025 - Greenwich LifeSciences Extends Lock-up of Directors and Officers to September 30, 2026
• 12.22.2025 - Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy

Recent Filings

• 01.15.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.14.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.05.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 12.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.18.2025 - 8-K Current report
• 11.28.2025 - 4 Statement of changes in beneficial ownership of securities